Crescita Therapeutics
ON - TorontoBiotechnology
Focus: Crescita Therapeutics is a Toronto-based public biotech company focused on topical therapeutics with a neurology-focused pipeline. The company operates as a smaller player in the specialty pharma space with limited active development activity.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Crescita Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Crescita Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
1 in 5yr
PLIAGLIS
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak4.4yr
Company's sole marketed product; amide and ester-type local anesthetic combination providing core revenue, but patent expiration in 2031 poses material cliff risk within planning horizon.
Help build intelligence for Crescita Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.